Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation - PubMed (original) (raw)
Comparative Study
. 1995 Sep 30;346(8979):861-4.
doi: 10.1016/s0140-6736(95)92707-7.
Affiliations
- PMID: 7564669
- DOI: 10.1016/s0140-6736(95)92707-7
Free article
Comparative Study
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation
C Singaram et al. Lancet. 1995.
Free article
Abstract
Clinical studies suggest that gut disorders are common in Parkinson's disease, but the morphological basis is unknown. Depletion of dopamine-containing neurons in the central nervous system is a basic defect in Parkinson's disease. We compared colonic tissue from 11 patients with advanced Parkinson's disease, 17 with adenocarcinoma (normal tissue was studied), and five who underwent colectomy for severe constipation. Immunohistochemistry was used to stain myenteric and submucosal neurons for dopamine, tyrosine hydroxylase, and vasoactive intestinal polypeptide (VIP). Each class of neurons was quantified as a percentage of the total neuronal population stained for the marker protein gene product 9.5. Nine of the 11 Parkinson's disease patients had substantially fewer dopaminergic myenteric neurons than the other subjects (mean 0.4 [SE 0.2] vs 6.9 [2.3] in controls and 5.7 [2.0] in constipated subjects). There was very little difference between the groups in numbers of tyrosine-hydroxylase and VIP neurons. Two Parkinson's disease patients had similar distributions of all types of neurons, including dopaminergic myenteric neurons, to the controls. High-performance liquid chromatography showed lower levels of dopamine in the muscularis externa (but not mucosa) in four Parkinson's disease patients than in four controls (7.3 [5.1] vs 24.2 [4.6] nmol per g protein), but levels of dopamine metabolites were similar in the two groups. The identification of this defect of dopaminergic neurons in the enteric nervous system in Parkinson's disease may lead to better treatment of colorectal dysfunction in this disease.
Similar articles
- Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation.
Giancola F, Torresan F, Repossi R, Bianco F, Latorre R, Ioannou A, Guarino M, Volta U, Clavenzani P, Mazzoni M, Chiocchetti R, Bazzoli F, Travagli RA, Sternini C, De Giorgio R. Giancola F, et al. Neurogastroenterol Motil. 2017 May;29(5):10.1111/nmo.12995. doi: 10.1111/nmo.12995. Epub 2016 Nov 27. Neurogastroenterol Motil. 2017. PMID: 27891695 Free PMC article. - Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.
Sharrad DF, de Vries E, Brookes SJ. Sharrad DF, et al. J Comp Neurol. 2013 Feb 15;521(3):657-76. doi: 10.1002/cne.23198. J Comp Neurol. 2013. PMID: 22821666 - Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD.
Corbillé AG, Coron E, Neunlist M, Derkinderen P, Lebouvier T. Corbillé AG, et al. J Parkinsons Dis. 2014;4(4):571-6. doi: 10.3233/JPD-140422. J Parkinsons Dis. 2014. PMID: 25055959 - Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.
Awad RA. Awad RA. World J Gastroenterol. 2011 Dec 14;17(46):5035-48. doi: 10.3748/wjg.v17.i46.5035. World J Gastroenterol. 2011. PMID: 22171138 Free PMC article. Review. - Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?
Sharma A, Kurek J, Morgan JC, Wakade C, Rao SSC. Sharma A, et al. Curr Gastroenterol Rep. 2018 Jan 19;20(1):1. doi: 10.1007/s11894-018-0609-x. Curr Gastroenterol Rep. 2018. PMID: 29350301 Review.
Cited by
- Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis.
Harsanyiova J, Buday T, Kralova Trancikova A. Harsanyiova J, et al. Front Neurosci. 2020 Jun 17;14:626. doi: 10.3389/fnins.2020.00626. eCollection 2020. Front Neurosci. 2020. PMID: 32625058 Free PMC article. Review. - [Gastrointestinal dysfunction in idiopathic Parkinson's disease].
Del Tredici K, Jost WH. Del Tredici K, et al. Nervenarzt. 2012 Oct;83(10):1282-91. doi: 10.1007/s00115-012-3575-9. Nervenarzt. 2012. PMID: 22743836 Review. German. - Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice.
Lindahl M, Chalazonitis A, Palm E, Pakarinen E, Danilova T, Pham TD, Setlik W, Rao M, Võikar V, Huotari J, Kopra J, Andressoo JO, Piepponen PT, Airavaara M, Panhelainen A, Gershon MD, Saarma M. Lindahl M, et al. Neurobiol Dis. 2020 Feb;134:104696. doi: 10.1016/j.nbd.2019.104696. Epub 2019 Nov 26. Neurobiol Dis. 2020. PMID: 31783118 Free PMC article. - Behavioral phenotyping of mouse models of Parkinson's disease.
Taylor TN, Greene JG, Miller GW. Taylor TN, et al. Behav Brain Res. 2010 Jul 29;211(1):1-10. doi: 10.1016/j.bbr.2010.03.004. Epub 2010 Mar 6. Behav Brain Res. 2010. PMID: 20211655 Free PMC article. Review. - Constipation in neurological diseases.
Winge K, Rasmussen D, Werdelin LM. Winge K, et al. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):13-9. doi: 10.1136/jnnp.74.1.13. J Neurol Neurosurg Psychiatry. 2003. PMID: 12486259 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical